Cardiovascular Surgery

This channel includes news and new technology innovations for cardiac surgery. This includes coronary artery bypass grafts (CABG) and surgical valve replacements.

News | Heart Valve Technology

January 29, 2019 β€” LivaNova PLC announced the publication of three separate studies highlighting the performance of its ...

Home January 29, 2019
Home
News | Peripheral Artery Disease (PAD)

December 19, 2018 β€”Β A new set of appropriate use criteria (AUC) released Dec. 17 by a group of cardiovascular ...

Home December 19, 2018
Home
Videos | Advanced Visualization

This is an example of the FDA-cleared OpenSight augmented reality (AR) system for surgical planning from NovaRad at theΒ  ...

Home December 12, 2018
Home
News | Cardiovascular Surgery

December 11, 2018 β€” The scientific journal Nature recently published an article from Munich University Hospital which ...

Home December 11, 2018
Home
News | Heart Valve Technology

November 2, 2018 β€” Hospitals that routinely perform a heart valve replacement procedure requiring open heart surgery are ...

Home November 02, 2018
Home
News | Cardiovascular Surgery

October 25, 2018 β€” On Oct. 18, 2018, LivaNova issued a Medical Device Correction letter to inform customers of actions ...

Home October 25, 2018
Home
A patient who received the HeartMate III LVAD system showing off his external battery pack. He served as a patient ambassador in the Abbott booth at ACC 2018. The HeartMate III, with its magnetic levitated pump, showed a big reduction in clotting over previous LVADs in a key late-breaking trial at ACC earlier this year.
Feature | Heart Failure

October 19, 2018 β€” Abbott announced today that the HeartMate 3 Left Ventricular Assist Device (LVAD) has received U.S ...

Home October 19, 2018
Home
Two of the top videos in September both had to do with interventional cardiology hemodynamic support support protocols. The top piece of content in September is an interview on the protocols used to determine what device technology to use at Henry Ford Hospital in Detroit. Number 13 on the list is another video on late-breaking data presented TCT 2018 from the National Cardiogenic Shock Initiative (NCSI) where mortality was improved by 50 percent over the current standard of care. Pictured here are Abiomed
Feature | Dave Fornell, Editor

October 1, 2018 β€” Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) ...

Home October 01, 2018
Home
News | Congenital Heart

September 25, 2018 β€” Five-month-old Jack Palmer is home with his family in Kansas City after undergoing an extremely ...

Home September 25, 2018
Home
News | Cardiovascular Surgery

September 6, 2018 β€” While it is firmly established that the use of one internal thoracic artery can improve life ...

Home September 06, 2018
Home
News | Heart Valve Technology

July 26, 2018 β€” The number of patients undergoing mitral valve operations are at an all-time high, and new research ...

Home July 26, 2018
Home
News | Ventricular Assist Devices (VAD)

May 23, 2018 β€” Abbott has initiated a Class I recall of the HeartMate 3 Left Ventricular Assist System due to a ...

Home May 23, 2018
Home
The U.S. Food and Drug Administration (FDA) has approved Portola Pharmaceuticals' Andexxa, the first antidote indicated for patients treated with rivaroxaban (Xarelto) and apixaban (Eliquis), when reversal of anticoagulation is needed due to life-threatening or uncontrolled bleeding.
Feature | Antiplatelet and Anticoagulation Therapies

May 7, 2018 β€” The U.S. Food and Drug Administration (FDA) has approved Portola Pharmaceuticals' Andexxa, the first ...

Home May 07, 2018
Home
Subscribe Now